Skip to content

Evaluation of the Performance of a Diffuse Intravascular Coagulation Scoring Model in a Critically Ill Patient Population: A Multicenter Retrospective Cohort Study

Evaluation of the Performance of a Diffuse Intravascular Coagulation Scoring Model in a Critically Ill Patient Population: A Multicenter Retrospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100823
Enrollment
Unknown
Registered
2025-04-15
Start date
2021-09-01
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disseminated Intravascular Coagulation

Interventions

ICU patients:NA

Sponsors

The Sixth Affiliated Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Study Population: All adult patients admitted to the ICU for more than 24 hours at the Sixth Affiliated Hospital of Sun Yat-sen University from January 2021 to January 2024. As this is a retrospective study, informed consent was waived. Inclusion Criteria: 1.Patients aged 18 years or older. 2.Hospitalization for at least 72 hours. 3.ICU treatment for a minimum of 24 hours.

Exclusion criteria

Exclusion criteria: 1.Patients with previous ICU admissions (i.e., those not admitted to the ICU for the first time). 2.Patients with an anticipated survival time of =72 hours. 3.Patients whose incomplete clinical data could affect the study. 4.Patients with hematologic malignancies. 5.Patients aged <18 years. 6.Patients who received antiplatelet and/or anticoagulant therapy within one month prior to ICU admission. 7.Patients admitted solely for diagnostic examinations or hemodialysis. 8.Patients admitted for the treatment of venous thromboembolism (VTE). 9.Patients hospitalized due to chronic illnesses rather than acute internal medical conditions. 10.Patients who explicitly refuse participation in any research and decline the use of their hospitalization information upon admission.

Design outcomes

Primary

MeasureTime frame
30-day survival;

Countries

China

Contacts

Public ContactLi Xiaoyan

The Sixth Affiliated Hospital of Sun Yat-Sen University

lixyan5@mail.sysu.edu.cn+86 150 1841 9504

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026